Publication Name	World Journal of Clinical Urology
Manuscript ID	26361
Country	United States

Received	2016-04-06 08:39
Peer-Review Started	2016-04-08 11:19
To Make the First Decision	2016-07-05 12:19
Return for Revision	2016-07-14 10:51
Revised	2016-08-17 09:02
Second Decision	2016-12-14 18:41
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-12-28 15:24
Articles in Press	2016-12-28 15:24
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-02-28 16:17
Publish the Manuscript Online	2017-03-02 12:24

ISSN	2219-2816 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Review
Article Title	Contemporary management of upper tract urothelial cell carcinoma
Manuscript Source	Invited Manuscript
All Author List	Kellen Choi, Ryan McCafferty and Samuel Deem
Funding Agency and Grant Number
Corresponding Author	Kellen Choi, DO, Department of Urology, Charleston Area Medical Center, 3200 MacCorkle Ave, S.E., Charleston, WV 25304, United States. bchoi@alum.unthsc.edu
Key Words	Urothelial cell carcinoma; Diagnosis; Upper tract; Epidemiology; Risk factors; Treatment; Prognosis
Core Tip	To review the current literature on upper tract urothelial cell carcinoma (UTUCC) and provide a conte?mporary management plan for treatment based on best available evidence. Large randomized controlled trials are lacking in UTUCC due to the fortunately rare occurrence of the disease. Treatment recommendations for the primary lesion, imaging, and follow-up in this review are based on the stage and grade of the tumor. Early diagnosis and aggressive treatment remains the mainstay of therapy for UTUCC.
Publish Date	2017-03-02 12:24
Citation	Choi K, McCafferty R, Deem S. Contemporary management of upper tract urothelial cell carcinoma. World J Clin Urol 2017; 6(1): 1-9
URL	http://www.wjgnet.com/2219-2816/full/v6/i1/1.htm
DOI	http://dx.doi.org/10.5410/wjcu.v6.i1.1

Full Article (PDF)	WJCU-6-1.pdf
Full Article (Word)	WJCU-6-1.doc
Manuscript File	26361-Review.docx
Answering Reviewers	26361-Answering reviewers.pdf
Audio Core Tip	26361-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	26361-Conflict-of-interest statement.pdf
Copyright License Agreement	26361-Copyright assignment.pdf
Peer-review Report	26361-Peer-review(s).pdf
Scientific Misconduct Check	26361-Scientific misconduct check.pdf
Scientific Editor Work List	26361-Scientific editor work list.pdf